Organogenesis Inks Full-Building Lease with The Davis Companies in Rhode Island
The Davis Companies has secured a full-building lease agreement with Organogenesis Holdings Inc. at 100 Technology Way in Smithfield, Rhode Island. The property is an approximately 123,000-square-foot biomanufacturing facility. While the terms of the lease were not disclosed, the commitment marks a significant development in the state’s growing life sciences and biomanufacturing sector.
“In a competitive manufacturing and life sciences market, our lease agreement with Organogenesis demonstrates Davis’ commitment to providing premier tenant experiences in locations that best allow businesses to innovate and scale,” said Jon Needham, Senior Vice President of Asset Management at The Davis Companies. “We are thrilled to welcome Organogenesis to the building and to support their growth plans as the company leads in the biomanufacturing sector and enhances Rhode Island’s and greater New England’s innovation ecosystem.”
A major renovation project is already underway at the facility to upgrade its capabilities and support its use as a current Good Manufacturing Practice (cGMP) facility. The building features robust utility infrastructure, an essential component for high-capacity biomanufacturing operations.
Organogenesis was represented in the lease negotiation by Robert Coughlin and Bobby Jangro of JLL. Mark Winters and Tyler McGrail of Newmark represented The Davis Companies and the property.
This full-building lease reflects the continued expansion of biomanufacturing and regenerative medicine in the region and underscores Rhode Island’s potential as a key player in the New England life sciences hub.
